FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4301394032> ?p ?o ?g. }

• W4301394032 abstract "Background: Naoshuantong capsules (NC) are commonly used for the treatment of ischemic stroke. Experimental research and small-sample clinical trials have demonstrated that NC is effective in improving neurological recovery. Yet, there is a substantial lack of high-quality evidence on the precision treatment population of NC and long-term safety when making real-world clinical decisions. The acquisition of prospective longitudinal data in the real-world setting is essential to fully characterize the effectiveness and safety profile of NC for patients with ischemic stroke. Methods: The Vital real-world Experience regarding Naoshuantong capsules for Unselected ischemic Stroke (VENUS) registry is a prospective, multicenter, observational study aiming to register 5,000 patients. Eligible adult patients diagnosed with ischemic stroke and newly treated with NC within 30 days of symptom onset will be consecutively registered from 84 participating sites across the Chinese mainland. Baseline data will be recorded at the patient registry, and all patients will be regularly followed up at 2, 4, 8, and 12 weeks after the initial patient registry, and 180 days after ischemic stroke onset. The primary outcome is the distribution of scores on the modified Rankin Scale at 12 weeks after initial patient registry. Adverse events will be recorded during the study for NC safety assessment. Results: A total of 4,185 patients with ischemic stroke were enrolled, among which 37.06% patients were female. The average age of all patients was 65.22 years. The proportion of patients whose course of ischemic stroke was less than 14 days accounted for 93.45%. Conclusion: The VENUS registry is designed to comprehensively document medical data regarding NC treatment for ischemic stroke in real-world settings. The findings of this study will provide valuable insights into the clinical management of patients with ischemic stroke and the subsequent outcomes of the use of NC when included in the best clinical practice. Study registration: This study was registered with the Chinese Clinical Trial Registry (URL: http://www.chictr.org.cn/index.aspx, Unique identifier: ChiCTR1900025053)." @default.
• W4301394032 created "2022-10-05" @default.
• W4301394032 creator A5013936186 @default.
• W4301394032 creator A5022968526 @default.
• W4301394032 creator A5024136505 @default.
• W4301394032 creator A5061396145 @default.
• W4301394032 creator A5062802638 @default.
• W4301394032 creator A5075889094 @default.
• W4301394032 creator A5081059956 @default.
• W4301394032 creator A5088141052 @default.
• W4301394032 date "2022-10-05" @default.
• W4301394032 modified "2023-09-26" @default.
• W4301394032 title "Vital real-world experience regarding Naoshuantong capsules for unselected ischemic stroke (VENUS): Rationale, design, and baseline of a prospective, multicenter, observational study" @default.
• W4301394032 cites W1847168837 @default.
• W4301394032 cites W2008854521 @default.
• W4301394032 cites W2010187365 @default.
• W4301394032 cites W2013606890 @default.
• W4301394032 cites W2031799897 @default.
• W4301394032 cites W2058161128 @default.
• W4301394032 cites W2067395123 @default.
• W4301394032 cites W2074979738 @default.
• W4301394032 cites W2078103827 @default.
• W4301394032 cites W2084389213 @default.
• W4301394032 cites W2092001267 @default.
• W4301394032 cites W2138595885 @default.
• W4301394032 cites W2148080316 @default.
• W4301394032 cites W2155441883 @default.
• W4301394032 cites W2157724112 @default.
• W4301394032 cites W2167311298 @default.
• W4301394032 cites W2172825360 @default.
• W4301394032 cites W2460117772 @default.
• W4301394032 cites W2569387348 @default.
• W4301394032 cites W2746562707 @default.
• W4301394032 cites W2808133395 @default.
• W4301394032 cites W2913876336 @default.
• W4301394032 cites W2953282350 @default.
• W4301394032 cites W2954381706 @default.
• W4301394032 cites W2970293011 @default.
• W4301394032 cites W2982303713 @default.
• W4301394032 cites W3010733248 @default.
• W4301394032 cites W3033968611 @default.
• W4301394032 cites W3085944265 @default.
• W4301394032 cites W3103688353 @default.
• W4301394032 cites W3123805923 @default.
• W4301394032 cites W3158214818 @default.
• W4301394032 cites W3164908038 @default.
• W4301394032 cites W3191537557 @default.
• W4301394032 cites W3197233575 @default.
• W4301394032 cites W3198147927 @default.
• W4301394032 doi "https://doi.org/10.3389/fphar.2022.933258" @default.
• W4301394032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36278169" @default.
• W4301394032 hasPublicationYear "2022" @default.
• W4301394032 type Work @default.
• W4301394032 citedByCount "0" @default.
• W4301394032 crossrefType "journal-article" @default.
• W4301394032 hasAuthorship W4301394032A5013936186 @default.
• W4301394032 hasAuthorship W4301394032A5022968526 @default.
• W4301394032 hasAuthorship W4301394032A5024136505 @default.
• W4301394032 hasAuthorship W4301394032A5061396145 @default.
• W4301394032 hasAuthorship W4301394032A5062802638 @default.
• W4301394032 hasAuthorship W4301394032A5075889094 @default.
• W4301394032 hasAuthorship W4301394032A5081059956 @default.
• W4301394032 hasAuthorship W4301394032A5088141052 @default.
• W4301394032 hasBestOaLocation W43013940321 @default.
• W4301394032 hasConcept C126322002 @default.
• W4301394032 hasConcept C127413603 @default.
• W4301394032 hasConcept C1862650 @default.
• W4301394032 hasConcept C188816634 @default.
• W4301394032 hasConcept C194828623 @default.
• W4301394032 hasConcept C197934379 @default.
• W4301394032 hasConcept C23131810 @default.
• W4301394032 hasConcept C2780645631 @default.
• W4301394032 hasConcept C2780931571 @default.
• W4301394032 hasConcept C3020199598 @default.
• W4301394032 hasConcept C535046627 @default.
• W4301394032 hasConcept C541997718 @default.
• W4301394032 hasConcept C71924100 @default.
• W4301394032 hasConcept C78519656 @default.
• W4301394032 hasConceptScore W4301394032C126322002 @default.
• W4301394032 hasConceptScore W4301394032C127413603 @default.
• W4301394032 hasConceptScore W4301394032C1862650 @default.
• W4301394032 hasConceptScore W4301394032C188816634 @default.
• W4301394032 hasConceptScore W4301394032C194828623 @default.
• W4301394032 hasConceptScore W4301394032C197934379 @default.
• W4301394032 hasConceptScore W4301394032C23131810 @default.
• W4301394032 hasConceptScore W4301394032C2780645631 @default.
• W4301394032 hasConceptScore W4301394032C2780931571 @default.
• W4301394032 hasConceptScore W4301394032C3020199598 @default.
• W4301394032 hasConceptScore W4301394032C535046627 @default.
• W4301394032 hasConceptScore W4301394032C541997718 @default.
• W4301394032 hasConceptScore W4301394032C71924100 @default.
• W4301394032 hasConceptScore W4301394032C78519656 @default.
• W4301394032 hasLocation W43013940321 @default.
• W4301394032 hasLocation W43013940322 @default.
• W4301394032 hasLocation W43013940323 @default.
• W4301394032 hasOpenAccess W4301394032 @default.
• W4301394032 hasPrimaryLocation W43013940321 @default.
• W4301394032 hasRelatedWork W2042725485 @default.
• W4301394032 hasRelatedWork W2222342249 @default.
• W4301394032 hasRelatedWork W2409400224 @default.

• next